Dr. Wesley D. Ark

Jon Isaacson is an Otolaryngologist practicing medicine in Hershey, Pennsylvania. Dr. Isaacson is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Infant Hearing Loss, Jones Syndrome, DFNB1, Cholesteatoma, and Myringotomy.

Roger Levin is an Otolaryngologist practicing medicine in Hershey, Pennsylvania. Dr. Levin is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, Renal Oncocytoma, Gastrostomy, and Laryngectomy.

Dr. Carole Fakhry is a head and neck surgical oncologist at Johns Hopkins and treats the breadth of patients with head and neck cancers, including cancers of the tonsils, base of tongue, mouth, larynx, thyroid, salivary gland (parotid, submandibular gland) and skin cancers among others. She is the Chief of the Division of Head and Neck Surgery and Director of the Head and Neck Cancer Center. She also serves as director of the head and neck group in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the head and neck surgical oncology fellowship. She is the associate editor for Oral Oncology and serves on several editorial boards. After an undergraduate degree at Stanford University, she completed medical school, residency in otolaryngology head and neck surgery, and a fellowship in head and neck surgical oncology at Johns Hopkins. She has also received a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She is presently a professor in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Oncology, and Johns Hopkins Bloomberg School of Public Health Department of Epidemiology. Her research interest focuses on the role of human papillomavirus (HPV) in head and neck squamous cell cancer. She has demonstrated that the presence of HPV confers a prognostic advantage to individuals with oropharyngeal cancer and that HPV is associated with unique clinical characteristics. In addition to the clinical implications of HPV in head and neck cancer, she is co-principal investigator of a large study to understand screening individuals at “high risk” of malignancy and evaluating imaging modalities to improve diagnostics and early detection of HPV- related head and neck cancer. Dr. Fakhry is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Human Papillomavirus Infection, Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, Laryngectomy, and Gastrostomy. Dr. Fakhry is board certified in Head And Neck Surgery.